ESSA PHARMA INC's ticker is EPIX and the CUSIP is 29668H708. A total of 61 filers reported holding ESSA PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,080 | +162.8% | 12,000 | +129.7% | 0.00% | – |
| Q2 2023 | $14,107 | -9.1% | 5,225 | 0.0% | 0.00% | – |
| Q1 2023 | $15,518 | +19.4% | 5,225 | 0.0% | 0.00% | – |
| Q4 2022 | $13,000 | +62.5% | 5,225 | +23.7% | 0.00% | – |
| Q3 2022 | $8,000 | -38.5% | 4,225 | 0.0% | 0.00% | – |
| Q2 2022 | $13,000 | -50.0% | 4,225 | 0.0% | 0.00% | – |
| Q1 2022 | $26,000 | -60.0% | 4,225 | -7.3% | 0.00% | – |
| Q4 2021 | $65,000 | +27.5% | 4,559 | -28.8% | 0.00% | – |
| Q3 2021 | $51,000 | -92.3% | 6,401 | -72.4% | 0.00% | -100.0% |
| Q2 2021 | $662,000 | +3.8% | 23,165 | +5.6% | 0.00% | -50.0% |
| Q1 2021 | $638,000 | +282.0% | 21,945 | +56.8% | 0.00% | – |
| Q4 2020 | $167,000 | +153.0% | 14,000 | +47.4% | 0.00% | – |
| Q3 2020 | $66,000 | +11.9% | 9,500 | 0.0% | 0.00% | – |
| Q2 2020 | $59,000 | +73.5% | 9,500 | +11.8% | 0.00% | – |
| Q1 2020 | $34,000 | – | 8,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Soleus Capital Management, L.P. | 2,070,052 | $60,135,000 | 10.84% |
| Burrage Capital Management LLC | 237,442 | $6,898,000 | 5.59% |
| Asymmetry Capital Management, L.P. | 284,459 | $8,264,000 | 4.28% |
| BVF INC/IL | 2,908,326 | $84,487,000 | 3.17% |
| Stenahm Asset Managment Ltd | 147,113 | $4,274,000 | 3.01% |
| ACUTA CAPITAL PARTNERS, LLC | 287,000 | $8,337,000 | 3.01% |
| Avidity Partners Management LP | 2,840,000 | $82,502,000 | 2.28% |
| Vivo Capital, LLC | 2,068,907 | $60,102,000 | 2.11% |
| COMMODORE CAPITAL LP | 176,821 | $5,137,000 | 2.05% |
| Ally Bridge Group (NY) LLC | 363,185 | $10,551,000 | 2.02% |